GENEWATCH
 
Volume 24 Issue 2
 
 
Volume 24 Issue 2
Bioengineering Animals
Apr-May 2011
 
Ethical Limits to Bioengineering Animals
By Paul Root Wolpe
 
Musical Genes
By CRG staff - interview with Greg Lukianoff
 
Sacred Ground
By Samuel W. Anderson
 
Food and Drug Amalgamation
By Eric Hoffman
 
Food Unchained
By Samuel W. Anderson
 
Goat Pharming
By CRG staff - interview with William Gavin of GTC Biotherapeutics
 
Back on "The Farm"
By Rob DeSalle
 
Gallery: Bioengineered Animals
By CRG Staff
 
Topic Update: Federal Circuit Hears Appeal in Myriad Gene Patent Case
By CRG Staff
 
SARS in the City
By Lynn C. Klotz
 
Gene Patenting in Canada
By James J. Rusthoven
 
Unnatural Selection
By CRG staff - interview with Mara Hvistendahl
 
Massachusetts Legislature Holds Hearing on Genetic Bill of Rights
By Jeremy Gruber
 
Editorial
By Samuel W. Anderson
 
 
Search: GeneWatch
 
 
 
The use of forensic DNA databases by law enforcement around the globe is expanding at a rate that should be of great concern to civil libertarians.
 
View Project
 
 
Rapid developments in biotechnology over the last two decades have enabled corporations and scientists to alter nature's handiwork for commercial profit. The patent, a tool originally created to insure that inventors could share in the financial returns and benefits deriving from the use of their nventions, has become the primary mechanism through which the private sector advances its claims to ownership over genes, proteins, and entire organisms.
 
View Project
 
 
Tools
PAGE TOOLS
 
 
 
 
ON THE WEB